Information  X 
Enter a valid email address

PureTech Health PLC (PRTC)

  Print   

Tuesday 10 May, 2022

PureTech Health PLC

Transaction in Own Shares

RNS Number : 8566K
PureTech Health PLC
10 May 2022
 

9 May 2022

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase: 

9 May 2022



Number of ordinary shares purchased:

29,545



Highest price paid per share:

170.20p



Lowest price paid per share:

161.00p



Volume weighted average price paid per share:

163.88p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 29,545 ordinary shares in treasury and has 287,871,859 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 287,871,859, which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules. 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

About PureTech Health

PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others. The Company has created a broad and deep pipeline through the expertise of its experienced research and development team and its extensive network of scientists, clinicians and industry leaders.

This pipeline, which is being advanced both internally and through PureTech's Founded Entities, is comprised of 27 therapeutics and therapeutic candidates, including two that have received both U.S. FDA clearance and European marketing authorization, as of the date of PureTech's most recently filed Annual Report and corresponding Form 6-K. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points based on unique insights in immunology and drug development.

For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

9/5/2022

16:27:41

27

164.4

XLON

00299880486TRLO0.1.1

9/5/2022

16:26:58

436

164

XLON

00299879966TRLO0.1.1

9/5/2022

16:22:44

292

164

XLON

00299876299TRLO0.1.1

9/5/2022

16:20:20

518

162.8

XLON

00299874463TRLO0.1.1

9/5/2022

16:19:08

423

162.8

XLON

00299873695TRLO0.1.1

9/5/2022

16:16:46

599

162

XLON

00299872485TRLO0.1.1

9/5/2022

16:14:29

327

162

XLON

00299871132TRLO0.1.1

9/5/2022

16:12:10

322

162

XLON

00299870130TRLO0.1.1

9/5/2022

16:10:04

322

162

XLON

00299869061TRLO0.1.1

9/5/2022

16:08:05

60

161.8

XLON

00299868137TRLO0.1.1

9/5/2022

16:08:05

248

161.8

XLON

00299868136TRLO0.1.1

9/5/2022

16:05:42

324

162

XLON

00299867005TRLO0.1.1

9/5/2022

16:03:24

324

162

XLON

00299866083TRLO0.1.1

9/5/2022

15:54:55

91

163.2

XLON

00299862758TRLO0.1.1

9/5/2022

15:54:55

206

163.2

XLON

00299862757TRLO0.1.1

9/5/2022

15:49:07

378

161.8

XLON

00299860673TRLO0.1.1

9/5/2022

15:45:46

309

161.8

XLON

00299859443TRLO0.1.1

9/5/2022

15:43:33

327

161.8

XLON

00299858682TRLO0.1.1

9/5/2022

15:39:53

135

161.8

XLON

00299857450TRLO0.1.1

9/5/2022

15:39:53

183

161.8

XLON

00299857449TRLO0.1.1

9/5/2022

15:37:50

263

162

XLON

00299856600TRLO0.1.1

9/5/2022

15:33:59

258

161.4

XLON

00299855088TRLO0.1.1

9/5/2022

15:32:01

42

162.2

XLON

00299854205TRLO0.1.1

9/5/2022

15:32:01

216

162.2

XLON

00299854204TRLO0.1.1

9/5/2022

15:29:59

328

162.4

XLON

00299853217TRLO0.1.1

9/5/2022

15:29:59

984

162.4

XLON

00299853216TRLO0.1.1

9/5/2022

15:15:40

304

161.6

XLON

00299847329TRLO0.1.1

9/5/2022

15:12:26

18

161.6

XLON

00299846025TRLO0.1.1

9/5/2022

15:10:04

296

162

XLON

00299845009TRLO0.1.1

9/5/2022

15:10:04

271

162

XLON

00299845008TRLO0.1.1

9/5/2022

15:10:04

313

162

XLON

00299845006TRLO0.1.1

9/5/2022

15:10:04

270

162

XLON

00299845007TRLO0.1.1

9/5/2022

15:10:04

273

162

XLON

00299845005TRLO0.1.1

9/5/2022

15:10:04

136

162

XLON

00299845004TRLO0.1.1

9/5/2022

15:10:04

273

162

XLON

00299845003TRLO0.1.1

9/5/2022

15:10:04

29

162

XLON

00299845002TRLO0.1.1

9/5/2022

15:10:04

108

162

XLON

00299845001TRLO0.1.1

9/5/2022

14:46:19

507

162.8

XLON

00299834214TRLO0.1.1

9/5/2022

14:41:42

305

164.2

XLON

00299832373TRLO0.1.1

9/5/2022

14:39:06

257

164.8

XLON

00299831239TRLO0.1.1

9/5/2022

14:36:59

315

165

XLON

00299830208TRLO0.1.1

9/5/2022

14:36:59

315

165

XLON

00299830207TRLO0.1.1

9/5/2022

14:34:59

315

165.4

XLON

00299829304TRLO0.1.1

9/5/2022

14:26:43

300

162.4

XLON

00299825449TRLO0.1.1

9/5/2022

14:21:48

1938

162.8

XLON

00299824202TRLO0.1.1

9/5/2022

14:21:48

323

162.8

XLON

00299824201TRLO0.1.1

9/5/2022

13:38:45

268

161

XLON

00299813109TRLO0.1.1

9/5/2022

13:28:48

319

162.4

XLON

00299810723TRLO0.1.1

9/5/2022

13:21:21

300

162.8

XLON

00299809024TRLO0.1.1

9/5/2022

13:15:46

400

162.8

XLON

00299807569TRLO0.1.1

9/5/2022

13:04:46

429

163

XLON

00299804912TRLO0.1.1

9/5/2022

13:00:06

301

163

XLON

00299803848TRLO0.1.1

9/5/2022

12:47:10

355

163

XLON

00299800934TRLO0.1.1

9/5/2022

12:40:34

79

163.4

XLON

00299799330TRLO0.1.1

9/5/2022

12:40:34

232

163.4

XLON

00299799329TRLO0.1.1

9/5/2022

12:33:41

222

163.4

XLON

00299797692TRLO0.1.1

9/5/2022

12:33:41

72

163.4

XLON

00299797691TRLO0.1.1

9/5/2022

12:23:30

528

163.4

XLON

00299795276TRLO0.1.1

9/5/2022

12:10:51

408

163.4

XLON

00299792405TRLO0.1.1

9/5/2022

12:10:51

94

163.4

XLON

00299792404TRLO0.1.1

9/5/2022

12:04:52

304

163.4

XLON

00299791055TRLO0.1.1

9/5/2022

11:55:42

34

163

XLON

00299788911TRLO0.1.1

9/5/2022

11:55:42

91

163

XLON

00299788910TRLO0.1.1

9/5/2022

11:55:42

195

163

XLON

00299788909TRLO0.1.1

9/5/2022

11:47:56

301

163

XLON

00299787156TRLO0.1.1

9/5/2022

11:38:46

391

163.4

XLON

00299784783TRLO0.1.1

9/5/2022

11:31:58

103

164.6

XLON

00299783222TRLO0.1.1

9/5/2022

11:31:58

122

164.6

XLON

00299783224TRLO0.1.1

9/5/2022

11:31:58

103

164.4

XLON

00299783221TRLO0.1.1

9/5/2022

11:28:07

313

164.2

XLON

00299782196TRLO0.1.1

9/5/2022

11:23:43

322

164.2

XLON

00299781225TRLO0.1.1

9/5/2022

11:23:43

261

164.2

XLON

00299781224TRLO0.1.1

9/5/2022

11:23:43

296

164.2

XLON

00299781223TRLO0.1.1

9/5/2022

11:23:40

26

164.2

XLON

00299781190TRLO0.1.1

9/5/2022

10:50:39

38

163.8

XLON

00299772941TRLO0.1.1

9/5/2022

10:50:39

464

163.8

XLON

00299772940TRLO0.1.1

9/5/2022

10:48:33

268

164.2

XLON

00299772432TRLO0.1.1

9/5/2022

10:48:33

1072

164.2

XLON

00299772431TRLO0.1.1

9/5/2022

10:08:08

191

163.8

XLON

00299761342TRLO0.1.1

9/5/2022

10:08:08

268

164.2

XLON

00299761343TRLO0.1.1

9/5/2022

09:57:56

383

164.8

XLON

00299758703TRLO0.1.1

9/5/2022

09:53:13

453

164.8

XLON

00299757391TRLO0.1.1

9/5/2022

09:53:13

89

164.8

XLON

00299757390TRLO0.1.1

9/5/2022

09:51:20

263

164.8

XLON

00299756943TRLO0.1.1

9/5/2022

09:32:36

297

163.6

XLON

00299751082TRLO0.1.1

9/5/2022

09:30:10

311

164.4

XLON

00299750164TRLO0.1.1

9/5/2022

09:21:17

330

165.6

XLON

00299747673TRLO0.1.1

9/5/2022

09:12:38

324

168

XLON

00299745226TRLO0.1.1

9/5/2022

09:06:37

114

168

XLON

00299743294TRLO0.1.1

9/5/2022

09:06:37

197

168

XLON

00299743293TRLO0.1.1

9/5/2022

09:06:37

16

168

XLON

00299743292TRLO0.1.1

9/5/2022

09:03:46

268

170

XLON

00299742240TRLO0.1.1

9/5/2022

09:03:46

457

170.2

XLON

00299742238TRLO0.1.1

9/5/2022

09:03:46

117

170.2

XLON

00299742239TRLO0.1.1

9/5/2022

09:03:46

929

170.2

XLON

00299742237TRLO0.1.1

9/5/2022

09:03:44

264

170.2

XLON

00299742216TRLO0.1.1

9/5/2022

09:03:44

465

170.2

XLON

00299742215TRLO0.1.1

9/5/2022

09:03:44

36

170.2

XLON

00299742214TRLO0.1.1

9/5/2022

09:03:31

254

170.2

XLON

00299742138TRLO0.1.1

 

Contact:

PureTech

Investor Relations

[email protected]

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFLTEIIAIIF

a d v e r t i s e m e n t